key: cord-0864663-kx8g3588 authors: Davies, Benjamin; Kenia, Priti; Nagakumar, Prasad; Gupta, Atul title: Paediatric and adolescent asthma: A narrative review of telemedicine and emerging technologies for the post‐COVID‐19 era date: 2021-02-10 journal: Clin Exp Allergy DOI: 10.1111/cea.13836 sha: 829330e31510b235eeeb672b563ce024d6db89c3 doc_id: 864663 cord_uid: kx8g3588 Children and young people with asthma need regular monitoring to maintain good asthma control, prevent asthma attacks and manage comorbidities. The COVID‐19 pandemic has resulted in healthcare professionals making fundamental changes to the way healthcare is delivered and for patients and families adapting to these changes. Comprehensive remotely delivered, technology‐based healthcare, closer to the patients home (reducing hospital footfall and possibly reducing carbon footprint) is likely to be one of the important collateral effects of the pandemic. Telemedicine is anticipated to impact everyone involved in healthcare ‐ providers and patients alike. It is going to bring changes to organization, work areas and work culture in healthcare. Healthcare providers, policymakers and those accessing healthcare services will experience the impact of technology‐based healthcare delivery. Telemedicine can play an exciting role in the management of childhood asthma by delivering high‐quality care closer to the child's home. However, unlike adults, children still need to be accompanied by their carers for virtual care. Policymakers will need to take into account potential additional costs as well as the legal, ethical and cultural implications of large scale use of telemedicine. In this narrative review, we review evidence regarding the role of telemedicine and related emerging technologies in paediatric and adolescent asthma. Although there are gaps in the current knowledge, there is evidence demonstrating the important role of telemedicine in management of childhood and adolescent asthma. However, there is an urgent need for healthcare researchers and policymakers to focus on improving the technologies and address the disparities in accessing novel technology‐based management strategies to improve asthma care. The COVID-19 pandemic presents a significant challenge in striving to ensure ongoing medical care for patients while simultaneously attempting to minimize risk of exposure of staff, children and families to infection in hospital or outpatient clinics. This has led to a rapid shift in outpatient working with implementation of telemedicine to reduce or replace face-to-face visits. 1, 2 Telemedicine overcomes the barrier of distance and is valuable in providing multidisciplinary care. Although the rapid adoption of telemedicine has been necessary to provide business continuity in the face of an acute reduction in traditional face-to-face clinical consultations, it is also timely to consider the variety of digital technologies available to paediatric asthma services in the "pandemic recovery phase" or post-COVID-19 era. Even before the current pandemic, there was recognition of the maturity of technology solutions for delivering telemedicine and debate about an increasing role for such consultations alongside, or even instead of, traditional in-person medical reviews. 3 Telemedicine has been increasingly of interest over the last decade as a means of improving asthma outcomes with a particular emphasis upon problematic and "difficult-to-manage" asthma. There are, however, concerns among health care professionals, young people and their families about issues such as access, confidentiality and the implications for safeguarding. There are many subtle variations in the definition of telemedicine in the literature. The literal meaning of telemedicine is also the most functional: tele-is a prefix denoting "at or over a distance" while medicine refers to the practice of the prevention, alleviation and cure of disease as well as the maintenance of health. Our definition of telemedicine is adapted from Miller 4 and the Cochrane review of telemedicine interventions for asthma. 5 Telemedicine consists of three domains, 1. . Information obtained from the patient 2. . Electronic transfer of this information to a health care professional over a distance 3. . Delivery of personalized feedback tailored to the patient Telemedicine refers to clinical healthcare applications, while the broader term "telehealth" is used more widely to describe both clinical and non-clinical applications, for example health education, administration and research. "Emerging technologies" are the devices or interfaces which aim to improve virtual care such as smartphone applications, web-based services for adherence and virtual presence devices. Telemedicine can comprise many different technologies applicable to delivering paediatric and adolescent asthma services including telephone consultations, video consultations, e-mail correspondence and remote patient monitoring. Such technologies are usually described as asynchronous or synchronous 6 and the key differences are illustrated in Figure 1 . Asynchronous telemedicine is where the communication between patient and healthcare provider occurs despite them not being connected simultaneously, for example interpretation of diagnostic tests or e-mail correspondence of patient questionnaires including C-ACT or PAQLQ. This type of telemedicine encounter has the advantage of requiring less coordination of the availability of patient and healthcare provider. Synchronous telemedicine refers to an encounter where both patient and healthcare provider are connected concurrently. Although this necessitates coordination of personnel, the response to clinical questions can take place in real time. F I G U R E 1 Schematic illustrating the key differences in asynchronous and synchronous telemedicine in paediatric asthma. In practice, these are complementary rather than exclusive strategies Recent systematic review 7 identified five studies (three randomized and two cohort) that utilized synchronous (real-time) telemedically delivered education for schoolchildren with asthma. These studies demonstrated that the effect upon asthma symptom management, symptom burden and Quality of Life were either positive or non-significant. This narrative review examines the outcomes in children with asthma for both synchronous and asynchronous telemedicine interventions in both school and clinic-based settings. We describe the role of telemedicine and emerging technologies in the management of children with asthma and highlight cost-implications and pitfalls in the wider adoption of these in the post-COVID era. We have widened the scope of review to include both synchronous and asynchronous telemedicine as well as to incorporate the use of "emerging technologies" such as smartphone applications, web-based services for adherence and virtual presence devices. We also include the use of these technologies outside school-based settings. We searched Cochrane, PubMed, CINAHL, ERIC and Embase using MeSH terms and keywords related to asthma and telemedicine. Searches were completed in June 2020, limiting studies to those conducted in the previous 20 years such that internet connectivity and communications technology would be most similar to that available today. One hundred and forty studies were available using the search criteria of "(telemedicine / telehealth / e-health / virtual visit / remote consult / e-consult / remote monitoring), asthma, (school / school-based)". One author screened each abstract, conducted full text review, assessed study quality and extracted information. Two authors independently reviewed this appraisal and all authors conducted synthesis and analysis for narrative review. There is a relatively limited number of randomized controlled trials specifically addressing clinical outcomes with telemedicine. However, there is a larger body of evidence examining the impact of school- A 2019 Cochrane Review identified 55 studies examining which components of school-based interventions were successful and the effect upon asthma control, school attendance and presentation to hospital or General Practitioner. 8 Self-management describes a process of education and enabling children to achieve adequate control over their own asthma symptoms including a focus upon proper inhaler technique and ability to recognize / respond to asthma symptoms. Meta-analysis suggested school-based self-management interventions reduced mean hospitalization by 0.16 admissions per child over 12 months. There was a decrease in the proportion of Emergency Department visits (from 7.5% to 5.4%) over 12 months and a reduction in unplanned hospital or primary care visits (from 26% to 21%) at 6-9 months. 6 | CLINI C ALOUTCOME SOF SYN CHRONOUSTELEMEDICINEFOR PAEDIATRICA S THMA A combination of school-based supervision with telemedicine was assessed by the SB-TEAM randomized controlled trial which enrolled 400 children aged 3 to 10 years in New York, USA. 9 The intervention was a combination of school-supervised asthma therapy and between 1-3 telemedicine visits over the course of one school year. History and examination data were gathered by telemedicine assistants. Assessment and patient feedback was completed by a clinician by either telephone or videoconference. Symptom-free days, emergency department visits and asthma hospitalization (OR 0.52) were better in the intervention group compared to children who did not receive either directly observed therapy or telemedicine visits. However, although the comparison group received guideline-based feedback and advice based upon reported symptoms at a similar interval to telemedicine interventions, this group also did not undertake directly observed therapy. It is therefore difficult to separate the contribution of the telemedicine element of the intervention from the effect of school-supervised asthma therapy itself. 10 Synchronous telemedicine in regular video asthma education sessions was combined with asynchronous telemonitoring of spirometry data in a randomized controlled trial enrolling 393 children aged 7-14 from rural schools in Arkansas, USA. 11 Children were randomized to their usual care from a Primary Care Provider or to the telemedicine programme. The programme involved a number of asthma education sessions provided for children, their caregivers and school nurse. Five interactive video education sessions were conducted with the child over a 5-9 week period. These were delivered alongside two video education sessions for the caregivers and one for the school nurse. Video sessions comprised asthma education, symptom recognition, use of reliever / controller medications, use of a personalized asthma medication plan and proper use of asthma medication devices and spacers. This assessment was completed by asynchronous information gathering using asthma questionnaires and spirometry at baseline and after 3 months. The "usual care" arm of the study received medical care from their primary care provider and completed follow-up surveys at the same interval as the "telemedicine" arm of the study. There was no statistically significant difference in the primary outcome measure of symptomfree days, nor in other outcome measures including quality of life questionnaires or spirometry. We identified two other studies that examined the clinical outcomes of synchronous telemedicine in school-aged children with asthma. Seventeen patients aged 5-18 years with persistent asthma symptoms in a rural school setting in the USA 12 had an initial specialist face-to-face assessment to perform spirometry, confirm asthma diagnosis and provide an asthma action plan. Patients were reassessed at 4, 12 and 24 weeks by remote nurse consultation together with spirometry. There was an improvement in symptom-free days and quality of life (measured by the asthma caregiver's quality of life questionnaire). However, in the absence of a comparison group, these results are subject to bias from temporal or asthma seasonal effects. Ninety six children aged 5-12 years with mild to moderate asthma were recruited to a prospective cohort study from three inner-city schools in the USA. 13 Children and an on-site school nurse participated in video consultations with an asthma specialist clinician at baseline and then at 8, 16 and 32 weeks. There were no significant changes in spirometry, hospital admissions nor Emergency Department / Primary Care visits. A group of 169 children with asthma were offered an alternative implementation of synchronous telemedicine, a "Remote Presence Solution". 14 Instead of simple telephone or videoconference based consultation, this involves the real-time use of a high-resolution camera for examination in combination with digital stethoscope, otoscope and spirometry. Children and their families self-allocated to either three telemedicine or usual in-person visits over a 6-month period. There was no inferiority demonstrated in C-ACT and family satisfaction scores between the two groups. We identified two studies reporting the outcome of asynchronous telemedicine on clinical outcomes in children with asthma. Twenty four children aged 6-12 years with asthma were enrolled in a web- A similar study involving an interactive record of symptoms, peak flow and patient-reported medication use for 41 children with asthma was supplemented over a 6-month period by monthly asthma education sessions delivered by an asthma nurse at school. 16 A 67% decrease in missed school days was reported although follow-up rates beyond 6 months precluded further analysis. The evidence to support clinical efficacy of virtual asthma care, whether delivered by synchronous or asynchronous telemedicine is limited. Much of the existing research into telemedicine is focused upon acceptability and technical feasibility rather than clinical outcomes. Only three studies employing a randomized controlled trial design were identified in the literature. An overview of the study population and description of the telemedicine intervention in the cited studies is provided in Table 1 . Table 2 High-financial cost is a concern frequently raised about the development of telemedicine practice. A randomized controlled trial across eight asthma centres in the Netherlands examined 210 school-aged children with asthma over a 16-month follow-up period. 17 Children were randomized to either their usual care (comprising 4-monthly outpatient visits) or to 8-monthly outpatient visits combined with monthly web-based monitoring. Children receiving the latter "virtual asthma clinic" review demonstrated better symptom-free days and improved Childhood Asthma Control Test score. This suggests that monthly virtual asthma care is at least as effective as routine in-person visits. A priori cost-effectiveness analysis was performed in parallel to the above multi-centre Netherlands study. 18 In general, spirometry is performed in the hospital setting for children with asthma as part of long-term monitoring and assessment of acute asthma attacks. Spirometry is a valuable part of respiratory patient assessment that requires special consideration of how this data can be acquired when reviewing patients by telemedicine instead of in hospital. A concern about remote monitoring is the potential for discrepancy between lung function measurements at home and those that would be obtained by trained staff as part of an "in-person" clinical assessment. Remote assessment of FEV 1 now is now technically feasible with the potential for useful clinical information and is being increasingly adopted for children with asthma during the COVID-19 pandemic. Digital remote consulting can make it harder to hear the young person's story and fully understand their perspective if the parent or carer is always present. It is more difficult to ensure that a consultation is confidential on both sides of the screen, and the ability to do so is also affected by inequalities such as access to private space. Although we assume young people prefer to engage digitally, they have told us that is not always the case. 25 An effective consultation needs a protected space and the full attention of both the clinician and the young person. This can be harder to achieve when people are using the flexibility offered by mobile technology rather than meeting face-to-face. It can be more difficult in a remote consultation to observe and react to nonverbal cues, for example the body language between a young person and the accompanying adult that would alert the clinician to a possible safeguarding issue. Use of digital consultation should be combined with a consistently low threshold for face-to-face consultation if there is any suggestion of a safeguarding concern or need for physical examination. 26 Social deprivation can result in barriers to accessing telemedicine (e.g., poor internet access, living in temporary accommodation, language barriers and poor access to interpreters). The potential of increasing adoption of telemedicine to widen health inequality in children with asthma is therefore a serious concern. Conversely, telemedicine has the potential to address barriers in access to care, for example by delivering specialist healthcare in regions without local access to specialists and in reducing the travel burden for families. 27 In Table 1 The COVID-19 pandemic has accelerated the adoption of telemedicine in health care. Rather than a "one size fits all" approach, the role of telemedicine in children needs to be evaluated by well-designed research studies. In particular, its role in reducing asthma attacks, improving asthma control, use by ethnic minority groups and comparing cost-effectiveness with traditional face-to-face delivery of healthcare needs to be explored in both primary and secondary health care systems. Children, young people, parents and health care provider views should be evaluated rigorously. Telemedicine and emerging technologies have the potential to revolutionize future healthcare delivery to children and young people with asthma. Young people and carers should be involved in designing the technology and delivery of telemedicine. It is likely that the health care sector will have access to multiple telemedicine platforms. Future telemedicine platforms should be rigorously evaluated by adequately powered clinical trials. The interface between various platforms is crucial for improving communication between patients and health care providers. Collaborative and collective working between professionals and teams can also be enabled in place of "silo working". Future technologies should focus on platforms to improve adherence to asthma medications, arrange repeat prescriptions and provide regular asthma education in the family's native language. Developments in Artificial Intelligence and algorithm-based monitoring could transform asthma education, self-management and provide early warning of acute asthma attacks. Healthcare policy and clinical governance will have to adapt to such innovations and to forge acceptable links with "big data" technology companies. The greatest advantage of telemedicine is in overcoming the barriers of distance and time and the focus should be to make the technology available to all to improve asthma care in children. BD, PK and PN have no conflicts of interest to declare. AG has no conflicts of interest directly related to this paper but reports fees for lecturing / advisory board work from: GlaxoSmithKline, Novartis Pharmaceuticals, Boehringer Ingelheim and Astra Zeneca. AG has been CI/PI of clinical trials with GlaxoSmithKline, Novartis Pharmaceuticals, Boehringer Ingelheim and Airsonett for which his institution has been paid. AG is also a director of the non-profit organization Paediatric Respiratory Academy which organizes educational meetings. Data sharing is not applicable to this article as no new data were created or analysed in this study. Benjamin Davies https://orcid.org/0000-0002-8441-4037 Prasad Nagakumar https://orcid.org/0000-0003-0837-0308 Atul Gupta https://orcid.org/0000-0002-1610-0335 Use of telemedicine and virtual care for remote treatment in response to COVID-19 pandemic Covid-19 and health care's digital revolution In-person health care as option B Miller EA Solving the disjuncture between research and practice: telehealth trends in the 21st century. Health Policy Telehealthcare for asthma: a cochrane review Telemedicine: a primer Telemedical asthma education and health care outcomes for school-age children: a systematic review School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review Effect of the schoolbased telemedicine enhanced asthma management (SB-TEAM) program on asthma morbidity: a randomized clinical trial Randomized controlled trial to improve care for urban children with asthma: results of the School-Based Asthma Therapy trial Results of an asthma education program delivered via telemedicine in rural schools Improvement in asthma symptoms and quality of life in pediatric patients through specialty care delivered via telemedicine The use of telemedicine access to schools to facilitate expert assessment of children with asthma Telemedicine is as effective as in-person visits for patients with asthma Computer-assisted school-based asthma management: a pilot study School-based asthma disease management A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control Online asthma management for children is cost-effective Assessment of a low-cost home monitoring spirometer for children Evaluating the use of a portable spirometer in a study of pediatric asthma Discrepancy between lung function measurements at home and in the hospital in children with asthma and CF Impact of eHealth on medication adherence among patients with asthma: a systematic review and meta-analysis Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic Digital by default" or digital divide? Virtual healthcare consultations with young people 10-25 years -Association for Young People's Health National Asthma and COPD Audit Programme, Royal College of Physicians, London. Improving outcomes for children with asthma: role of national audit Implementing telehealth in pediatric asthma Digital approaches to remote pediatric health care delivery during the COVID-19 pandemic: existing evidence and a call for further research Paediatric and adolescent asthma: A narrative review of telemedicine and emerging technologies for the post COVID-19 era